Literature DB >> 23656712

HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?

Christoph Neumann-Haefelin1.   

Abstract

PURPOSE OF REVIEW: HLA-B27 is associated with low viral load and long-term nonprogression in HIV infection as well as spontaneous clearance of hepatitis C virus (HCV) infection. This review summarizes mechanisms that have been suggested to be involved in this protective effect of HLA-B27, and highlights possible lessons for the role of HLA-B27 in spondyloarthritis. RECENT
FINDINGS: Recent studies linked protection by HLA-B27 in HIV and HCV infection to virological mechanisms such as a complicated pathways of viral escape from immunodominant HLA-B27-restricted virus-specific CD8+ T-cell epitopes. In addition, several immunological mechanisms have been proposed, including CD8+ T-cell polyfunctionality and functional avidity, thymic selection of CD8+ T-cell precursors, specific T-cell receptor repertoires and clonotypes, efficient antigen processing, and evasion from regulatory T-cell-mediated suppression.
SUMMARY: Multiple virological and immunological mechanisms have been suggested to contribute to HLA-B27-mediated protection in HIV and HCV infection. Some of these mechanisms may also be involved in HLA-B27-associated pathogenesis in spondyloarthritis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23656712     DOI: 10.1097/BOR.0b013e328362018f

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

Review 1.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

2.  The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.

Authors:  Hiroko Hatano; Jacqueline Shaw; Kaitlin Marquardt; Zhiyong Zhang; Laurent Gauthier; Stephanie Chanteux; Benjamin Rossi; Demin Li; Julie Mitchell; Simon Kollnberger
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

Review 3.  The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

Authors:  C Vitulano; V Tedeschi; F Paladini; R Sorrentino; M T Fiorillo
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

Review 4.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

5.  Egypt's groundwork blessing during the COVID-19 pandemic curse: Rheumatologic experience.

Authors:  Tamer A Gheita; Sanaa A Kenawy
Journal:  Eur J Rheumatol       Date:  2020-04-15

Review 6.  An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).

Authors:  Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

7.  The Ankylosing Spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients.

Authors:  Valentina Tedeschi; Carolina Vitulano; Alberto Cauli; Fabiana Paladini; Matteo Piga; Alessandro Mathieu; Rosa Sorrentino; Maria Teresa Fiorillo
Journal:  Mol Med       Date:  2016-05-18       Impact factor: 6.354

8.  HLA genotypes and rubella vaccine immune response: additional evidence.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Beth R Larrabee; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2014-05-15       Impact factor: 3.641

9.  Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation.

Authors:  Valentina Tedeschi; Josephine Alba; Fabiana Paladini; Marino Paroli; Alberto Cauli; Alessandro Mathieu; Rosa Sorrentino; Marco D'Abramo; Maria Teresa Fiorillo
Journal:  Cells       Date:  2019-06-11       Impact factor: 6.600

10.  KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals.

Authors:  Xin Zhang; Xiaofan Lu; Christiane Moog; Lin Yuan; Zhiying Liu; Zhen Li; Wei Xia; Yuefang Zhou; Hao Wu; Tong Zhang; Bin Su
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.